Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammasomes | 95 | 2025 | 331 | 18.520 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 78 | 2025 | 256 | 12.110 |
Why?
|
Inflammation | 81 | 2024 | 1101 | 7.720 |
Why?
|
Macrophages | 66 | 2025 | 1006 | 7.070 |
Why?
|
Immunity, Innate | 50 | 2024 | 766 | 5.950 |
Why?
|
Atherosclerosis | 18 | 2022 | 147 | 5.260 |
Why?
|
Interleukin-1beta | 45 | 2024 | 265 | 4.970 |
Why?
|
Signal Transduction | 74 | 2024 | 2890 | 4.560 |
Why?
|
Toll-Like Receptors | 34 | 2025 | 434 | 4.000 |
Why?
|
Carrier Proteins | 29 | 2023 | 710 | 3.770 |
Why?
|
Microglia | 18 | 2025 | 227 | 3.500 |
Why?
|
Animals | 197 | 2025 | 19608 | 3.250 |
Why?
|
Alzheimer Disease | 19 | 2025 | 549 | 2.660 |
Why?
|
Mice | 141 | 2025 | 10254 | 2.600 |
Why?
|
Cholesterol | 13 | 2020 | 255 | 2.260 |
Why?
|
Caspase 1 | 25 | 2025 | 110 | 2.240 |
Why?
|
Mice, Inbred C57BL | 74 | 2025 | 3187 | 2.220 |
Why?
|
Cytokines | 31 | 2024 | 906 | 2.220 |
Why?
|
Humans | 229 | 2025 | 59303 | 2.190 |
Why?
|
Toll-Like Receptor 4 | 26 | 2021 | 348 | 2.150 |
Why?
|
Toll-Like Receptor 9 | 21 | 2024 | 197 | 2.010 |
Why?
|
Receptors, Cell Surface | 24 | 2022 | 439 | 1.990 |
Why?
|
Diet, Western | 4 | 2019 | 8 | 1.970 |
Why?
|
Lysosomes | 18 | 2025 | 162 | 1.960 |
Why?
|
Interleukin-18 | 15 | 2021 | 74 | 1.940 |
Why?
|
Neurodegenerative Diseases | 6 | 2025 | 127 | 1.850 |
Why?
|
Monocytes | 19 | 2021 | 351 | 1.840 |
Why?
|
Apoptosis Regulatory Proteins | 13 | 2024 | 149 | 1.800 |
Why?
|
Interleukin-1 | 11 | 2022 | 155 | 1.760 |
Why?
|
Membrane Glycoproteins | 22 | 2021 | 669 | 1.720 |
Why?
|
Mice, Knockout | 51 | 2025 | 1988 | 1.660 |
Why?
|
Inflammation Mediators | 12 | 2021 | 169 | 1.630 |
Why?
|
Endosomes | 8 | 2021 | 170 | 1.600 |
Why?
|
DNA | 16 | 2024 | 793 | 1.580 |
Why?
|
Dendritic Cells | 21 | 2021 | 509 | 1.560 |
Why?
|
Immunologic Memory | 6 | 2021 | 276 | 1.490 |
Why?
|
Lipopolysaccharides | 19 | 2020 | 645 | 1.450 |
Why?
|
RNA | 5 | 2021 | 404 | 1.440 |
Why?
|
Immune System | 4 | 2020 | 129 | 1.400 |
Why?
|
Interferon-beta | 7 | 2021 | 76 | 1.370 |
Why?
|
CARD Signaling Adaptor Proteins | 14 | 2021 | 63 | 1.330 |
Why?
|
Cells, Cultured | 38 | 2021 | 2103 | 1.310 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 350 | 1.210 |
Why?
|
Toll-Like Receptor 7 | 12 | 2024 | 97 | 1.200 |
Why?
|
Cell Line | 44 | 2021 | 2014 | 1.190 |
Why?
|
HEK293 Cells | 21 | 2024 | 577 | 1.190 |
Why?
|
Toll-Like Receptor 8 | 9 | 2024 | 44 | 1.180 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 72 | 1.180 |
Why?
|
Receptors, Pattern Recognition | 3 | 2014 | 31 | 1.160 |
Why?
|
Receptors, Immunologic | 13 | 2014 | 178 | 1.150 |
Why?
|
Amyloid beta-Peptides | 11 | 2025 | 189 | 1.130 |
Why?
|
Host-Pathogen Interactions | 8 | 2021 | 239 | 1.100 |
Why?
|
Membrane Transport Proteins | 4 | 2024 | 119 | 1.100 |
Why?
|
Pyroptosis | 4 | 2021 | 32 | 1.090 |
Why?
|
Nucleic Acids | 3 | 2016 | 50 | 1.080 |
Why?
|
Cell Death | 10 | 2024 | 267 | 1.080 |
Why?
|
Brain | 9 | 2025 | 1487 | 1.060 |
Why?
|
NF-kappa B | 17 | 2024 | 461 | 1.050 |
Why?
|
Adaptive Immunity | 4 | 2021 | 90 | 1.030 |
Why?
|
Oligodeoxyribonucleotides | 12 | 2021 | 243 | 1.020 |
Why?
|
Cytoskeletal Proteins | 6 | 2017 | 194 | 1.010 |
Why?
|
Crystallization | 8 | 2018 | 97 | 0.970 |
Why?
|
ATP Citrate (pro-S)-Lyase | 3 | 2024 | 17 | 0.930 |
Why?
|
Extracellular Vesicles | 2 | 2022 | 41 | 0.920 |
Why?
|
Multiprotein Complexes | 5 | 2018 | 150 | 0.920 |
Why?
|
Phagocytes | 5 | 2018 | 49 | 0.910 |
Why?
|
Flow Cytometry | 13 | 2018 | 671 | 0.890 |
Why?
|
Autoimmunity | 5 | 2024 | 223 | 0.860 |
Why?
|
Adaptor Proteins, Signal Transducing | 14 | 2024 | 416 | 0.850 |
Why?
|
Fluorescence Resonance Energy Transfer | 3 | 2016 | 72 | 0.840 |
Why?
|
Silicosis | 2 | 2016 | 4 | 0.840 |
Why?
|
Familial Mediterranean Fever | 1 | 2022 | 9 | 0.830 |
Why?
|
Immune System Diseases | 2 | 2020 | 17 | 0.830 |
Why?
|
Microscopy, Fluorescence | 5 | 2016 | 397 | 0.820 |
Why?
|
Interleukin-6 | 7 | 2023 | 309 | 0.820 |
Why?
|
Bacterial Toxins | 1 | 2022 | 60 | 0.800 |
Why?
|
Gene Expression Regulation | 13 | 2019 | 1537 | 0.800 |
Why?
|
Receptor for Advanced Glycation End Products | 5 | 2016 | 19 | 0.780 |
Why?
|
Pyrin | 2 | 2022 | 7 | 0.780 |
Why?
|
Autoimmune Diseases | 5 | 2016 | 222 | 0.780 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 11 | 0.780 |
Why?
|
DNA-Binding Proteins | 17 | 2025 | 1128 | 0.760 |
Why?
|
Interferon Type I | 8 | 2023 | 169 | 0.750 |
Why?
|
Vasculitis | 1 | 2021 | 49 | 0.750 |
Why?
|
Homeostasis | 4 | 2019 | 340 | 0.750 |
Why?
|
Myeloid Differentiation Factor 88 | 12 | 2021 | 209 | 0.740 |
Why?
|
Lipoproteins, HDL | 3 | 2019 | 36 | 0.740 |
Why?
|
Gastrointestinal Microbiome | 7 | 2022 | 195 | 0.730 |
Why?
|
HMGB1 Protein | 4 | 2018 | 25 | 0.720 |
Why?
|
Lipopolysaccharide Receptors | 8 | 2018 | 143 | 0.720 |
Why?
|
Disulfiram | 1 | 2020 | 4 | 0.720 |
Why?
|
Bone Marrow Cells | 5 | 2018 | 231 | 0.680 |
Why?
|
Acetyl Coenzyme A | 1 | 2019 | 23 | 0.680 |
Why?
|
Biomarkers | 13 | 2024 | 1205 | 0.670 |
Why?
|
Interferons | 2 | 2018 | 64 | 0.670 |
Why?
|
Interleukin-1alpha | 4 | 2022 | 25 | 0.670 |
Why?
|
Disease Models, Animal | 21 | 2025 | 2062 | 0.660 |
Why?
|
Bacteria | 3 | 2017 | 276 | 0.660 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 76 | 0.650 |
Why?
|
beta-Cyclodextrins | 2 | 2016 | 25 | 0.650 |
Why?
|
Ligands | 4 | 2016 | 422 | 0.650 |
Why?
|
Plaque, Atherosclerotic | 5 | 2021 | 27 | 0.640 |
Why?
|
Protein Binding | 18 | 2021 | 1550 | 0.630 |
Why?
|
Apoptosis | 7 | 2023 | 1038 | 0.630 |
Why?
|
Pneumonia | 3 | 2022 | 263 | 0.630 |
Why?
|
Exons | 1 | 2019 | 193 | 0.620 |
Why?
|
Alternative Splicing | 1 | 2019 | 120 | 0.620 |
Why?
|
Gout | 2 | 2016 | 53 | 0.620 |
Why?
|
Anti-Inflammatory Agents | 5 | 2024 | 157 | 0.600 |
Why?
|
Leukocytes, Mononuclear | 7 | 2021 | 238 | 0.600 |
Why?
|
Microbiota | 5 | 2022 | 106 | 0.600 |
Why?
|
CpG Islands | 7 | 2010 | 212 | 0.600 |
Why?
|
Kidney Diseases | 5 | 2021 | 157 | 0.600 |
Why?
|
Cellular Reprogramming | 1 | 2018 | 32 | 0.590 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2024 | 156 | 0.590 |
Why?
|
Clone Cells | 1 | 2018 | 106 | 0.590 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 68 | 0.580 |
Why?
|
Microscopy, Confocal | 14 | 2019 | 219 | 0.580 |
Why?
|
Activating Transcription Factor 3 | 2 | 2015 | 7 | 0.580 |
Why?
|
Molecular Chaperones | 1 | 2018 | 97 | 0.580 |
Why?
|
B-Lymphocytes | 5 | 2014 | 550 | 0.580 |
Why?
|
Mitochondria | 6 | 2025 | 333 | 0.570 |
Why?
|
Transcription, Genetic | 6 | 2019 | 847 | 0.570 |
Why?
|
Kidney | 6 | 2021 | 391 | 0.570 |
Why?
|
Caspase 8 | 2 | 2019 | 61 | 0.570 |
Why?
|
Histones | 2 | 2019 | 463 | 0.560 |
Why?
|
Toll-Like Receptor 2 | 14 | 2021 | 220 | 0.560 |
Why?
|
Membrane Proteins | 7 | 2024 | 843 | 0.550 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2024 | 158 | 0.550 |
Why?
|
Sulfones | 6 | 2019 | 40 | 0.550 |
Why?
|
Alarmins | 1 | 2016 | 4 | 0.550 |
Why?
|
Macrophage Activation | 5 | 2021 | 119 | 0.550 |
Why?
|
Interleukin-33 | 1 | 2016 | 18 | 0.550 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 177 | 0.540 |
Why?
|
S100 Proteins | 1 | 2016 | 21 | 0.540 |
Why?
|
Stress, Physiological | 1 | 2018 | 185 | 0.540 |
Why?
|
Phagocytosis | 10 | 2025 | 252 | 0.540 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 202 | 0.530 |
Why?
|
Green Fluorescent Proteins | 5 | 2018 | 353 | 0.530 |
Why?
|
Asbestosis | 1 | 2016 | 1 | 0.530 |
Why?
|
Autophagy | 5 | 2024 | 205 | 0.520 |
Why?
|
tau Proteins | 6 | 2023 | 103 | 0.520 |
Why?
|
Aging | 2 | 2019 | 722 | 0.520 |
Why?
|
Kupffer Cells | 3 | 2025 | 42 | 0.520 |
Why?
|
Nuclear Proteins | 8 | 2014 | 759 | 0.520 |
Why?
|
Disease Progression | 6 | 2025 | 1039 | 0.500 |
Why?
|
Furans | 6 | 2022 | 36 | 0.490 |
Why?
|
Reactive Oxygen Species | 12 | 2025 | 201 | 0.480 |
Why?
|
Adaptor Protein Complex 1 | 1 | 2014 | 2 | 0.480 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2014 | 6 | 0.480 |
Why?
|
Liver | 6 | 2025 | 784 | 0.480 |
Why?
|
Scavenger Receptors, Class E | 1 | 2014 | 4 | 0.470 |
Why?
|
Liquid Crystals | 2 | 2020 | 3 | 0.470 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 5 | 2019 | 25 | 0.470 |
Why?
|
Cognitive Dysfunction | 4 | 2023 | 261 | 0.460 |
Why?
|
Sulfonamides | 6 | 2022 | 123 | 0.460 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2021 | 580 | 0.450 |
Why?
|
Interferon Regulatory Factors | 2 | 2013 | 39 | 0.450 |
Why?
|
Immunotherapy | 2 | 2018 | 229 | 0.440 |
Why?
|
Apolipoproteins E | 3 | 2016 | 99 | 0.440 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2013 | 22 | 0.440 |
Why?
|
Genes, Reporter | 6 | 2016 | 243 | 0.440 |
Why?
|
Antigen Presentation | 6 | 2024 | 228 | 0.440 |
Why?
|
Endoplasmic Reticulum | 4 | 2019 | 167 | 0.430 |
Why?
|
Succinates | 2 | 2024 | 8 | 0.430 |
Why?
|
Male | 43 | 2025 | 27480 | 0.430 |
Why?
|
fas Receptor | 2 | 2012 | 54 | 0.430 |
Why?
|
Shock, Septic | 2 | 2012 | 90 | 0.430 |
Why?
|
Aorta | 2 | 2022 | 103 | 0.420 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2012 | 9 | 0.400 |
Why?
|
Clonal Anergy | 1 | 2012 | 23 | 0.400 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 78 | 0.400 |
Why?
|
Lung Diseases | 1 | 2013 | 163 | 0.400 |
Why?
|
Intestines | 2 | 2015 | 157 | 0.400 |
Why?
|
Eosinophils | 2 | 2025 | 51 | 0.390 |
Why?
|
Models, Biological | 9 | 2021 | 1139 | 0.390 |
Why?
|
Transcriptome | 6 | 2021 | 324 | 0.390 |
Why?
|
Fibrosis | 5 | 2019 | 151 | 0.390 |
Why?
|
Tetracycline | 2 | 2022 | 20 | 0.390 |
Why?
|
Calcium-Binding Proteins | 1 | 2012 | 85 | 0.390 |
Why?
|
Cytosol | 5 | 2021 | 169 | 0.390 |
Why?
|
Nitric Oxide | 1 | 2012 | 144 | 0.380 |
Why?
|
Neutrophils | 4 | 2021 | 354 | 0.380 |
Why?
|
alpha-Synuclein | 2 | 2021 | 20 | 0.380 |
Why?
|
Aortic Diseases | 1 | 2012 | 67 | 0.380 |
Why?
|
Proteomics | 3 | 2023 | 252 | 0.380 |
Why?
|
Transcatheter Aortic Valve Replacement | 2 | 2024 | 95 | 0.380 |
Why?
|
Indenes | 6 | 2022 | 17 | 0.370 |
Why?
|
Receptors, LDL | 3 | 2018 | 33 | 0.360 |
Why?
|
Mice, Transgenic | 11 | 2025 | 1221 | 0.360 |
Why?
|
Nucleotidyltransferases | 4 | 2024 | 54 | 0.360 |
Why?
|
Metabolic Diseases | 1 | 2011 | 51 | 0.360 |
Why?
|
Cell Membrane | 7 | 2013 | 492 | 0.360 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 4 | 2018 | 32 | 0.360 |
Why?
|
Protein Isoforms | 4 | 2019 | 195 | 0.360 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 168 | 0.360 |
Why?
|
Glycolysis | 3 | 2020 | 54 | 0.350 |
Why?
|
Amyloid | 3 | 2020 | 61 | 0.350 |
Why?
|
Nucleotides, Cyclic | 3 | 2021 | 13 | 0.340 |
Why?
|
Aptamers, Nucleotide | 3 | 2019 | 18 | 0.340 |
Why?
|
Immune Tolerance | 2 | 2021 | 169 | 0.330 |
Why?
|
Glucocorticoids | 2 | 2024 | 170 | 0.330 |
Why?
|
Receptors, Cytokine | 1 | 2009 | 14 | 0.330 |
Why?
|
Protein Transport | 5 | 2018 | 394 | 0.330 |
Why?
|
Female | 32 | 2024 | 30798 | 0.330 |
Why?
|
Protein Multimerization | 5 | 2018 | 167 | 0.330 |
Why?
|
Adaptor Proteins, Vesicular Transport | 5 | 2019 | 83 | 0.330 |
Why?
|
Protein Domains | 3 | 2019 | 141 | 0.320 |
Why?
|
Killer Cells, Natural | 4 | 2022 | 214 | 0.320 |
Why?
|
Drosophila Proteins | 6 | 2003 | 681 | 0.320 |
Why?
|
THP-1 Cells | 5 | 2021 | 17 | 0.320 |
Why?
|
Sphingolipids | 2 | 2020 | 22 | 0.320 |
Why?
|
Uric Acid | 2 | 2021 | 49 | 0.320 |
Why?
|
Myeloid Cells | 3 | 2021 | 92 | 0.320 |
Why?
|
Caspase Inhibitors | 2 | 2022 | 21 | 0.320 |
Why?
|
Phosphorylation | 7 | 2021 | 861 | 0.310 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2014 | 250 | 0.310 |
Why?
|
Macrophages, Peritoneal | 3 | 2021 | 73 | 0.310 |
Why?
|
DNA, Bacterial | 3 | 2019 | 260 | 0.310 |
Why?
|
RNA, Double-Stranded | 5 | 2021 | 108 | 0.310 |
Why?
|
Peritonitis | 3 | 2019 | 33 | 0.310 |
Why?
|
Gene Expression Profiling | 7 | 2020 | 697 | 0.310 |
Why?
|
Acute Lung Injury | 2 | 2021 | 39 | 0.310 |
Why?
|
Complement System Proteins | 3 | 2020 | 126 | 0.310 |
Why?
|
Parkinson Disease | 2 | 2020 | 97 | 0.300 |
Why?
|
Amino Acid Sequence | 6 | 2019 | 1582 | 0.290 |
Why?
|
Recombinant Fusion Proteins | 8 | 2014 | 502 | 0.290 |
Why?
|
Bacterial Infections | 3 | 2019 | 139 | 0.290 |
Why?
|
HIV Infections | 4 | 2021 | 919 | 0.290 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 10 | 2018 | 454 | 0.290 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 255 | 0.290 |
Why?
|
Golgi Apparatus | 3 | 2016 | 64 | 0.290 |
Why?
|
Toll-Like Receptor 3 | 5 | 2024 | 67 | 0.290 |
Why?
|
STAT3 Transcription Factor | 2 | 2020 | 68 | 0.290 |
Why?
|
Virus Diseases | 3 | 2022 | 110 | 0.280 |
Why?
|
Blood Pressure | 3 | 2021 | 519 | 0.280 |
Why?
|
HIV-1 | 4 | 2021 | 707 | 0.280 |
Why?
|
Retinal Pigment Epithelium | 2 | 2019 | 26 | 0.280 |
Why?
|
Communicable Diseases | 2 | 2018 | 81 | 0.280 |
Why?
|
Life Style | 2 | 2019 | 328 | 0.270 |
Why?
|
Endothelial Cells | 3 | 2022 | 177 | 0.270 |
Why?
|
Interferon-alpha | 4 | 2023 | 99 | 0.270 |
Why?
|
Models, Molecular | 5 | 2021 | 1125 | 0.270 |
Why?
|
Lipoproteins, LDL | 3 | 2018 | 46 | 0.270 |
Why?
|
NLR Proteins | 3 | 2022 | 11 | 0.270 |
Why?
|
Cryopyrin-Associated Periodic Syndromes | 2 | 2017 | 3 | 0.270 |
Why?
|
MicroRNAs | 3 | 2022 | 617 | 0.260 |
Why?
|
Viral Proteins | 3 | 2016 | 260 | 0.260 |
Why?
|
Cell Communication | 3 | 2021 | 129 | 0.260 |
Why?
|
RNA, Bacterial | 2 | 2017 | 70 | 0.260 |
Why?
|
Neisseria meningitidis | 2 | 2004 | 104 | 0.260 |
Why?
|
Autoantigens | 1 | 2006 | 125 | 0.250 |
Why?
|
Oligonucleotides | 3 | 2017 | 208 | 0.250 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2022 | 125 | 0.250 |
Why?
|
Dysbiosis | 3 | 2022 | 56 | 0.250 |
Why?
|
Cathepsins | 2 | 2020 | 32 | 0.250 |
Why?
|
Retroviridae | 2 | 2018 | 73 | 0.250 |
Why?
|
Proteome | 2 | 2023 | 135 | 0.250 |
Why?
|
Filarioidea | 1 | 2025 | 1 | 0.250 |
Why?
|
Microfilariae | 1 | 2025 | 2 | 0.250 |
Why?
|
Antigens, Surface | 2 | 2003 | 191 | 0.250 |
Why?
|
DEAD-box RNA Helicases | 3 | 2011 | 77 | 0.250 |
Why?
|
Mice, Inbred BALB C | 4 | 2016 | 880 | 0.240 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2016 | 70 | 0.240 |
Why?
|
Pulmonary Fibrosis | 2 | 2022 | 53 | 0.240 |
Why?
|
Aqueous Humor | 1 | 2024 | 6 | 0.240 |
Why?
|
Antigens, Differentiation | 6 | 2005 | 140 | 0.240 |
Why?
|
Butyrates | 1 | 2024 | 13 | 0.240 |
Why?
|
Adenosine Deaminase | 1 | 2024 | 16 | 0.240 |
Why?
|
Propionates | 1 | 2024 | 19 | 0.240 |
Why?
|
Glutamine | 1 | 2025 | 47 | 0.240 |
Why?
|
Hypertension | 2 | 2021 | 600 | 0.240 |
Why?
|
Whole Genome Sequencing | 1 | 2024 | 61 | 0.240 |
Why?
|
Chemical and Drug Induced Liver Injury | 2 | 2025 | 41 | 0.230 |
Why?
|
Protein Structure, Tertiary | 8 | 2013 | 663 | 0.230 |
Why?
|
Acetaminophen | 2 | 2025 | 52 | 0.230 |
Why?
|
Cataract | 1 | 2024 | 54 | 0.230 |
Why?
|
Antibodies | 4 | 2023 | 177 | 0.230 |
Why?
|
Haemophilus Vaccines | 1 | 2004 | 5 | 0.230 |
Why?
|
Zellweger Syndrome | 1 | 2024 | 1 | 0.230 |
Why?
|
Peroxisomal Disorders | 1 | 2024 | 1 | 0.230 |
Why?
|
Metadata | 1 | 2024 | 14 | 0.230 |
Why?
|
Middle Aged | 17 | 2024 | 16231 | 0.230 |
Why?
|
Citric Acid Cycle | 2 | 2024 | 25 | 0.230 |
Why?
|
Lung | 4 | 2018 | 823 | 0.230 |
Why?
|
T-Lymphocytes | 6 | 2024 | 963 | 0.230 |
Why?
|
Polysaccharides, Bacterial | 1 | 2004 | 43 | 0.230 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2021 | 71 | 0.230 |
Why?
|
Apolipoprotein C-III | 2 | 2023 | 7 | 0.230 |
Why?
|
Extracellular Traps | 3 | 2025 | 40 | 0.220 |
Why?
|
Transduction, Genetic | 2 | 2018 | 233 | 0.220 |
Why?
|
Up-Regulation | 3 | 2021 | 363 | 0.220 |
Why?
|
Models, Immunological | 3 | 2015 | 79 | 0.220 |
Why?
|
Immunoblotting | 6 | 2018 | 190 | 0.220 |
Why?
|
Histiocytosis | 1 | 2023 | 4 | 0.220 |
Why?
|
Biological Transport | 2 | 2016 | 287 | 0.220 |
Why?
|
Phosphoproteins | 4 | 2017 | 216 | 0.220 |
Why?
|
NADPH Oxidases | 1 | 2003 | 64 | 0.220 |
Why?
|
Base Sequence | 6 | 2021 | 1312 | 0.220 |
Why?
|
Proteolysis | 2 | 2021 | 138 | 0.220 |
Why?
|
Antibodies, Antinuclear | 2 | 2018 | 35 | 0.220 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2014 | 145 | 0.220 |
Why?
|
Lymphocyte Antigen 96 | 4 | 2010 | 53 | 0.220 |
Why?
|
Enzyme Inhibitors | 3 | 2021 | 338 | 0.210 |
Why?
|
Chitinase-3-Like Protein 1 | 1 | 2023 | 11 | 0.210 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 396 | 0.210 |
Why?
|
Transcription Factors | 6 | 2014 | 1456 | 0.210 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2004 | 137 | 0.210 |
Why?
|
Caspases | 2 | 2016 | 164 | 0.210 |
Why?
|
Listeriosis | 3 | 2016 | 30 | 0.210 |
Why?
|
RNA, Small Interfering | 8 | 2018 | 851 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2016 | 675 | 0.210 |
Why?
|
Adjuvants, Immunologic | 4 | 2014 | 228 | 0.210 |
Why?
|
Disease Susceptibility | 2 | 2020 | 158 | 0.210 |
Why?
|
Nucleotide Motifs | 3 | 2017 | 44 | 0.210 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 156 | 0.200 |
Why?
|
Circulating MicroRNA | 1 | 2022 | 6 | 0.200 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 278 | 0.200 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2021 | 71 | 0.200 |
Why?
|
Aged | 13 | 2024 | 13285 | 0.200 |
Why?
|
Tyrosine | 2 | 2021 | 95 | 0.200 |
Why?
|
Ciliopathies | 1 | 2022 | 10 | 0.200 |
Why?
|
Aldehydes | 1 | 2022 | 16 | 0.200 |
Why?
|
Lysine | 2 | 2017 | 75 | 0.200 |
Why?
|
Sodium Chloride, Dietary | 2 | 2019 | 9 | 0.200 |
Why?
|
Receptors, Odorant | 1 | 2022 | 5 | 0.200 |
Why?
|
Nanoparticles | 2 | 2018 | 496 | 0.200 |
Why?
|
Interferon Regulatory Factor-3 | 8 | 2024 | 91 | 0.200 |
Why?
|
Orthomyxoviridae Infections | 3 | 2016 | 69 | 0.200 |
Why?
|
Binge-Eating Disorder | 1 | 2022 | 11 | 0.200 |
Why?
|
Enzyme Activation | 4 | 2024 | 353 | 0.200 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2023 | 607 | 0.200 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 1370 | 0.190 |
Why?
|
Cell Membrane Structures | 1 | 2021 | 8 | 0.190 |
Why?
|
Receptors, Interleukin-1 | 2 | 2013 | 64 | 0.190 |
Why?
|
Protein Aggregation, Pathological | 2 | 2019 | 17 | 0.190 |
Why?
|
Palatine Tonsil | 1 | 2021 | 10 | 0.190 |
Why?
|
Tauopathies | 1 | 2021 | 15 | 0.190 |
Why?
|
Acetylation | 2 | 2019 | 111 | 0.190 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2021 | 56 | 0.190 |
Why?
|
Cholesterol Esters | 1 | 2021 | 10 | 0.190 |
Why?
|
B7-H1 Antigen | 1 | 2021 | 53 | 0.190 |
Why?
|
Endoribonucleases | 1 | 2021 | 52 | 0.190 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 16 | 0.190 |
Why?
|
Neuronal Apoptosis-Inhibitory Protein | 1 | 2021 | 2 | 0.190 |
Why?
|
Adult | 14 | 2024 | 15729 | 0.190 |
Why?
|
Primary Cell Culture | 5 | 2021 | 75 | 0.190 |
Why?
|
Liver Cirrhosis | 2 | 2023 | 160 | 0.190 |
Why?
|
Microscopy, Atomic Force | 2 | 2012 | 28 | 0.190 |
Why?
|
SELEX Aptamer Technique | 2 | 2017 | 2 | 0.190 |
Why?
|
Intracellular Space | 2 | 2011 | 32 | 0.190 |
Why?
|
Cations | 2 | 2019 | 63 | 0.180 |
Why?
|
Cholesterol, LDL | 3 | 2021 | 105 | 0.180 |
Why?
|
Drug Discovery | 2 | 2019 | 91 | 0.180 |
Why?
|
Endocytosis | 3 | 2013 | 148 | 0.180 |
Why?
|
Docosahexaenoic Acids | 1 | 2021 | 30 | 0.180 |
Why?
|
Hemeproteins | 2 | 2014 | 17 | 0.180 |
Why?
|
Complement Activation | 3 | 2017 | 53 | 0.180 |
Why?
|
Ubiquitin | 1 | 2021 | 95 | 0.180 |
Why?
|
Liposomes | 2 | 2019 | 98 | 0.180 |
Why?
|
RAW 264.7 Cells | 4 | 2022 | 47 | 0.180 |
Why?
|
Fatty Acid Binding Protein 3 | 1 | 2020 | 3 | 0.180 |
Why?
|
DNA, Protozoan | 2 | 2014 | 35 | 0.180 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2021 | 63 | 0.180 |
Why?
|
Neurogranin | 1 | 2020 | 9 | 0.180 |
Why?
|
Cholestasis | 1 | 2021 | 52 | 0.180 |
Why?
|
Obesity | 3 | 2022 | 1189 | 0.180 |
Why?
|
Aged, 80 and over | 9 | 2024 | 5063 | 0.180 |
Why?
|
Saliva | 1 | 2021 | 96 | 0.180 |
Why?
|
Ferritins | 1 | 2020 | 32 | 0.180 |
Why?
|
Spatial Learning | 1 | 2020 | 2 | 0.180 |
Why?
|
Cilia | 1 | 2022 | 156 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 180 | 0.180 |
Why?
|
Autophagosomes | 1 | 2020 | 11 | 0.180 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2022 | 84 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 165 | 0.180 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 172 | 0.180 |
Why?
|
Phospholipase C gamma | 1 | 2020 | 9 | 0.180 |
Why?
|
Antiviral Agents | 1 | 2023 | 314 | 0.180 |
Why?
|
Autoantibodies | 2 | 2014 | 174 | 0.170 |
Why?
|
Carotid Artery Diseases | 1 | 2020 | 62 | 0.170 |
Why?
|
Long-Term Potentiation | 1 | 2020 | 43 | 0.170 |
Why?
|
Structure-Activity Relationship | 2 | 2021 | 376 | 0.170 |
Why?
|
Salmonella Infections | 1 | 2020 | 38 | 0.170 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 195 | 0.170 |
Why?
|
Kangai-1 Protein | 1 | 2019 | 3 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2022 | 280 | 0.170 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2019 | 2 | 0.170 |
Why?
|
NIMA-Related Kinases | 1 | 2019 | 5 | 0.170 |
Why?
|
Salmonella typhimurium | 1 | 2020 | 80 | 0.170 |
Why?
|
Ileus | 1 | 2019 | 6 | 0.170 |
Why?
|
Peptidomimetics | 1 | 2019 | 5 | 0.170 |
Why?
|
Down-Regulation | 4 | 2021 | 306 | 0.170 |
Why?
|
Feedback, Physiological | 1 | 2019 | 58 | 0.170 |
Why?
|
2-Hydroxypropyl-beta-cyclodextrin | 2 | 2016 | 6 | 0.170 |
Why?
|
Immunization | 4 | 2015 | 127 | 0.170 |
Why?
|
Stochastic Processes | 1 | 2019 | 26 | 0.170 |
Why?
|
Liver Neoplasms | 1 | 2022 | 274 | 0.170 |
Why?
|
Liver Diseases | 2 | 2018 | 137 | 0.170 |
Why?
|
Crystallography, X-Ray | 3 | 2020 | 422 | 0.160 |
Why?
|
Organ Specificity | 1 | 2019 | 178 | 0.160 |
Why?
|
Gene Expression | 4 | 2020 | 808 | 0.160 |
Why?
|
TNF Receptor-Associated Factor 6 | 2 | 2020 | 23 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 525 | 0.160 |
Why?
|
Galectins | 1 | 2018 | 7 | 0.160 |
Why?
|
Influenza A virus | 2 | 2013 | 117 | 0.160 |
Why?
|
Protein Interaction Mapping | 2 | 2016 | 71 | 0.160 |
Why?
|
DNA, Viral | 2 | 2010 | 228 | 0.160 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2018 | 11 | 0.160 |
Why?
|
Epithelial Cells | 1 | 2021 | 375 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 324 | 0.160 |
Why?
|
Immunoglobulin G | 2 | 2018 | 451 | 0.160 |
Why?
|
Antigen-Antibody Complex | 4 | 2012 | 49 | 0.160 |
Why?
|
Mutation | 3 | 2023 | 2427 | 0.160 |
Why?
|
CD36 Antigens | 2 | 2021 | 26 | 0.160 |
Why?
|
Gene Library | 1 | 2019 | 99 | 0.160 |
Why?
|
Protein Conformation | 4 | 2022 | 766 | 0.160 |
Why?
|
Luminescent Proteins | 3 | 2004 | 129 | 0.160 |
Why?
|
Cell Lineage | 2 | 2017 | 250 | 0.160 |
Why?
|
Cohort Studies | 6 | 2022 | 2435 | 0.160 |
Why?
|
Arginine | 1 | 2019 | 113 | 0.150 |
Why?
|
Swine | 1 | 2019 | 338 | 0.150 |
Why?
|
Membrane Microdomains | 2 | 2016 | 48 | 0.150 |
Why?
|
Lymphocyte Activation | 8 | 2016 | 740 | 0.150 |
Why?
|
Luciferases | 2 | 2013 | 109 | 0.150 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 500 | 0.150 |
Why?
|
Intestinal Mucosa | 2 | 2022 | 221 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 159 | 0.150 |
Why?
|
RNA, Viral | 5 | 2012 | 265 | 0.150 |
Why?
|
Protein Folding | 3 | 2015 | 256 | 0.150 |
Why?
|
Colchicine | 1 | 2018 | 27 | 0.150 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2018 | 8 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 2 | 2021 | 383 | 0.150 |
Why?
|
Hypertension, Portal | 1 | 2018 | 15 | 0.150 |
Why?
|
Blood Platelets | 1 | 2020 | 179 | 0.150 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2017 | 1 | 0.150 |
Why?
|
Protein Stability | 1 | 2018 | 82 | 0.150 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 128 | 0.150 |
Why?
|
Staphylococcus aureus | 2 | 2017 | 158 | 0.150 |
Why?
|
Chemokine CCL17 | 1 | 2017 | 2 | 0.150 |
Why?
|
Incretins | 1 | 2017 | 6 | 0.150 |
Why?
|
RNA Interference | 4 | 2016 | 589 | 0.150 |
Why?
|
Dermatitis, Contact | 1 | 2017 | 12 | 0.150 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 266 | 0.150 |
Why?
|
Ceramides | 1 | 2017 | 23 | 0.150 |
Why?
|
Interleukin-8 | 5 | 2019 | 84 | 0.150 |
Why?
|
Cyclodextrins | 1 | 2017 | 13 | 0.150 |
Why?
|
Seizures | 1 | 2018 | 117 | 0.150 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 72 | 0.150 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 21 | 0.150 |
Why?
|
Chemotaxis | 1 | 2017 | 47 | 0.150 |
Why?
|
Interleukin-4 | 1 | 2017 | 137 | 0.150 |
Why?
|
Viral Load | 5 | 2021 | 228 | 0.140 |
Why?
|
Tuberculosis | 1 | 2021 | 261 | 0.140 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 276 | 0.140 |
Why?
|
Friends | 1 | 2017 | 29 | 0.140 |
Why?
|
Phosphoserine | 1 | 2017 | 10 | 0.140 |
Why?
|
Spores, Bacterial | 1 | 2017 | 3 | 0.140 |
Why?
|
Protein Phosphatase 2 | 1 | 2017 | 10 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2024 | 1058 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2017 | 41 | 0.140 |
Why?
|
HeLa Cells | 2 | 2021 | 527 | 0.140 |
Why?
|
Synaptic Transmission | 1 | 2018 | 150 | 0.140 |
Why?
|
Amino Acid Motifs | 2 | 2014 | 152 | 0.140 |
Why?
|
Carotid Arteries | 1 | 2017 | 59 | 0.140 |
Why?
|
Agammaglobulinemia | 1 | 2017 | 8 | 0.140 |
Why?
|
Coronavirus Infections | 1 | 2020 | 186 | 0.140 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 10 | 0.140 |
Why?
|
Hypertension, Renal | 1 | 2016 | 3 | 0.140 |
Why?
|
Software | 2 | 2024 | 367 | 0.140 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 198 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 112 | 0.140 |
Why?
|
Blotting, Western | 5 | 2016 | 595 | 0.140 |
Why?
|
Influenza A Virus, H7N9 Subtype | 1 | 2016 | 7 | 0.140 |
Why?
|
Diabetic Neuropathies | 1 | 2016 | 9 | 0.140 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 26 | 0.140 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 1 | 2016 | 11 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 3 | 0.140 |
Why?
|
Transfection | 7 | 2013 | 673 | 0.140 |
Why?
|
Pinocytosis | 1 | 2016 | 4 | 0.140 |
Why?
|
Pyrimidines | 1 | 2017 | 123 | 0.140 |
Why?
|
Dental Calculus | 1 | 2016 | 2 | 0.140 |
Why?
|
Pyrazoles | 1 | 2017 | 74 | 0.140 |
Why?
|
Time Factors | 5 | 2020 | 3567 | 0.140 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2015 | 58 | 0.140 |
Why?
|
Receptors, IgG | 3 | 2018 | 36 | 0.140 |
Why?
|
Cell Nucleus | 2 | 2019 | 603 | 0.140 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2016 | 27 | 0.140 |
Why?
|
Simvastatin | 1 | 2016 | 28 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 643 | 0.140 |
Why?
|
Protein Interaction Maps | 1 | 2016 | 33 | 0.140 |
Why?
|
Ursodeoxycholic Acid | 1 | 2016 | 7 | 0.140 |
Why?
|
Nephritis | 1 | 2016 | 8 | 0.130 |
Why?
|
DEAD Box Protein 58 | 3 | 2011 | 18 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2017 | 176 | 0.130 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2016 | 26 | 0.130 |
Why?
|
Dexamethasone | 1 | 2017 | 191 | 0.130 |
Why?
|
Liver X Receptors | 1 | 2016 | 7 | 0.130 |
Why?
|
Sulfonylurea Compounds | 1 | 2016 | 14 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2017 | 113 | 0.130 |
Why?
|
Dermatitis | 1 | 2016 | 29 | 0.130 |
Why?
|
Immunity, Heterologous | 1 | 2016 | 11 | 0.130 |
Why?
|
ras Proteins | 1 | 2016 | 78 | 0.130 |
Why?
|
Gadolinium | 2 | 2014 | 101 | 0.130 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 869 | 0.130 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2018 | 219 | 0.130 |
Why?
|
Lupus Nephritis | 1 | 2016 | 31 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2016 | 810 | 0.130 |
Why?
|
Syndrome | 2 | 2014 | 173 | 0.130 |
Why?
|
Huntington Disease | 1 | 2017 | 146 | 0.130 |
Why?
|
Phase Transition | 1 | 2016 | 19 | 0.130 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 83 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 326 | 0.130 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 114 | 0.130 |
Why?
|
Receptors, Chemokine | 1 | 2015 | 32 | 0.130 |
Why?
|
Extracellular Matrix | 1 | 2016 | 130 | 0.130 |
Why?
|
Cell Proliferation | 2 | 2018 | 944 | 0.130 |
Why?
|
RNA, Ribosomal, 23S | 1 | 2015 | 8 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 607 | 0.130 |
Why?
|
Hyperlipidemias | 1 | 2015 | 38 | 0.130 |
Why?
|
Gingiva | 1 | 2015 | 7 | 0.130 |
Why?
|
Desoxycorticosterone Acetate | 3 | 2021 | 3 | 0.120 |
Why?
|
Streptococcus pyogenes | 1 | 2015 | 27 | 0.120 |
Why?
|
Lipofuscin | 1 | 2015 | 4 | 0.120 |
Why?
|
RNA Splicing | 1 | 2016 | 161 | 0.120 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 118 | 0.120 |
Why?
|
Mice, Inbred C3H | 2 | 2013 | 174 | 0.120 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2015 | 18 | 0.120 |
Why?
|
Silicon Dioxide | 2 | 2022 | 59 | 0.120 |
Why?
|
Mice, Mutant Strains | 5 | 2018 | 304 | 0.120 |
Why?
|
Calgranulin A | 1 | 2014 | 5 | 0.120 |
Why?
|
Calcium | 1 | 2018 | 555 | 0.120 |
Why?
|
Hyperoxia | 1 | 2014 | 16 | 0.120 |
Why?
|
Diet | 1 | 2019 | 635 | 0.120 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
Genotyping Techniques | 1 | 2014 | 14 | 0.120 |
Why?
|
Vaccines | 1 | 2016 | 97 | 0.120 |
Why?
|
Reactive Nitrogen Species | 1 | 2014 | 7 | 0.120 |
Why?
|
Nanotechnology | 1 | 2016 | 128 | 0.120 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2014 | 11 | 0.120 |
Why?
|
Colon | 1 | 2015 | 137 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 211 | 0.120 |
Why?
|
Prions | 1 | 2014 | 24 | 0.120 |
Why?
|
Peritoneum | 1 | 2014 | 25 | 0.120 |
Why?
|
Phagosomes | 2 | 2012 | 44 | 0.120 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 22 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 2014 | 50 | 0.110 |
Why?
|
Light | 1 | 2015 | 201 | 0.110 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 229 | 0.110 |
Why?
|
Saponins | 1 | 2014 | 28 | 0.110 |
Why?
|
Endonucleases | 1 | 2014 | 81 | 0.110 |
Why?
|
Adenosine Triphosphate | 3 | 2022 | 288 | 0.110 |
Why?
|
Biofilms | 1 | 2015 | 69 | 0.110 |
Why?
|
Bystander Effect | 1 | 2013 | 5 | 0.110 |
Why?
|
Mutation, Missense | 2 | 2014 | 179 | 0.110 |
Why?
|
Systems Biology | 1 | 2013 | 28 | 0.110 |
Why?
|
Colitis | 2 | 2015 | 76 | 0.110 |
Why?
|
Phospholipids | 1 | 2014 | 79 | 0.110 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 98 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2013 | 39 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 58 | 0.110 |
Why?
|
eIF-2 Kinase | 1 | 2013 | 10 | 0.110 |
Why?
|
Vaccination | 3 | 2022 | 337 | 0.110 |
Why?
|
Immunity | 1 | 2014 | 96 | 0.110 |
Why?
|
Peptides | 1 | 2016 | 548 | 0.110 |
Why?
|
Crystallins | 1 | 2013 | 4 | 0.110 |
Why?
|
Brain Injuries | 1 | 2015 | 140 | 0.110 |
Why?
|
Static Electricity | 1 | 2013 | 165 | 0.110 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2012 | 11 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2024 | 147 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2019 | 1127 | 0.100 |
Why?
|
Poly dA-dT | 2 | 2009 | 7 | 0.100 |
Why?
|
Phosphate-Binding Proteins | 2 | 2025 | 18 | 0.100 |
Why?
|
Virulence Factors | 1 | 2013 | 84 | 0.100 |
Why?
|
Malaria | 1 | 2014 | 101 | 0.100 |
Why?
|
Annexin A1 | 1 | 2012 | 3 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2017 | 474 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 8 | 0.100 |
Why?
|
Genetic Vectors | 3 | 2018 | 813 | 0.100 |
Why?
|
DNA, B-Form | 1 | 2012 | 2 | 0.100 |
Why?
|
Focal Adhesions | 1 | 2012 | 23 | 0.100 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 208 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 73 | 0.100 |
Why?
|
Contrast Media | 1 | 2014 | 408 | 0.100 |
Why?
|
Aortic Valve | 2 | 2024 | 164 | 0.100 |
Why?
|
Neointima | 1 | 2011 | 19 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2024 | 5141 | 0.090 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 1977 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2012 | 137 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2013 | 114 | 0.090 |
Why?
|
Mass Spectrometry | 3 | 2021 | 285 | 0.090 |
Why?
|
Escherichia coli | 3 | 2010 | 685 | 0.090 |
Why?
|
Blood Vessels | 1 | 2011 | 61 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2011 | 67 | 0.090 |
Why?
|
Influenza, Human | 1 | 2013 | 193 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 182 | 0.090 |
Why?
|
Coinfection | 1 | 2011 | 45 | 0.090 |
Why?
|
Diet, Atherogenic | 1 | 2010 | 7 | 0.090 |
Why?
|
Peritoneal Cavity | 1 | 2010 | 31 | 0.090 |
Why?
|
Cathepsin L | 1 | 2010 | 20 | 0.090 |
Why?
|
Cathepsin B | 1 | 2010 | 12 | 0.090 |
Why?
|
Spleen | 2 | 2025 | 485 | 0.090 |
Why?
|
Albuminuria | 2 | 2021 | 23 | 0.090 |
Why?
|
Young Adult | 5 | 2024 | 4318 | 0.090 |
Why?
|
DNA Virus Infections | 1 | 2010 | 9 | 0.090 |
Why?
|
Tularemia | 1 | 2010 | 17 | 0.090 |
Why?
|
Francisella tularensis | 1 | 2010 | 23 | 0.090 |
Why?
|
Sesquiterpenes | 1 | 2010 | 14 | 0.090 |
Why?
|
DNA Viruses | 1 | 2010 | 15 | 0.090 |
Why?
|
Glioblastoma | 1 | 2012 | 156 | 0.090 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 253 | 0.090 |
Why?
|
Sporozoites | 1 | 2009 | 4 | 0.090 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2010 | 35 | 0.090 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 79 | 0.090 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 133 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 92 | 0.080 |
Why?
|
Plasmodium berghei | 1 | 2009 | 20 | 0.080 |
Why?
|
Nitriles | 1 | 2010 | 59 | 0.080 |
Why?
|
RNA Polymerase III | 1 | 2009 | 9 | 0.080 |
Why?
|
Immunomodulation | 2 | 2021 | 27 | 0.080 |
Why?
|
Cytoplasm | 1 | 2011 | 273 | 0.080 |
Why?
|
Polyphosphates | 1 | 2009 | 12 | 0.080 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2009 | 58 | 0.080 |
Why?
|
RNA Viruses | 1 | 2009 | 8 | 0.080 |
Why?
|
Cell Line, Transformed | 3 | 2016 | 97 | 0.080 |
Why?
|
Macromolecular Substances | 1 | 2009 | 160 | 0.080 |
Why?
|
Antimalarials | 1 | 2009 | 68 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2021 | 1295 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 484 | 0.080 |
Why?
|
Precipitin Tests | 3 | 2004 | 79 | 0.080 |
Why?
|
Neutrophil Infiltration | 2 | 2022 | 61 | 0.080 |
Why?
|
Locomotion | 1 | 2009 | 108 | 0.080 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 515 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 98 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2017 | 1126 | 0.080 |
Why?
|
Aluminum Compounds | 1 | 2008 | 10 | 0.080 |
Why?
|
Antigen-Presenting Cells | 2 | 2023 | 176 | 0.080 |
Why?
|
Brain Neoplasms | 1 | 2012 | 306 | 0.080 |
Why?
|
Chaperonin 10 | 1 | 2008 | 5 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2009 | 188 | 0.080 |
Why?
|
Streptococcus agalactiae | 1 | 2008 | 80 | 0.080 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2008 | 15 | 0.080 |
Why?
|
Deoxyribose | 1 | 2008 | 1 | 0.080 |
Why?
|
In Vitro Techniques | 2 | 2012 | 475 | 0.080 |
Why?
|
Trypanosoma cruzi | 1 | 2008 | 49 | 0.080 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 37 | 0.080 |
Why?
|
Astrocytes | 2 | 2021 | 115 | 0.080 |
Why?
|
Arthritis, Experimental | 1 | 2008 | 29 | 0.070 |
Why?
|
Immunoprecipitation | 3 | 2014 | 116 | 0.070 |
Why?
|
Complement C5a | 2 | 2020 | 5 | 0.070 |
Why?
|
Doxorubicin | 2 | 2021 | 99 | 0.070 |
Why?
|
Psoriasis | 1 | 2008 | 51 | 0.070 |
Why?
|
Biological Transport, Active | 2 | 2006 | 39 | 0.070 |
Why?
|
Models, Animal | 2 | 2021 | 220 | 0.070 |
Why?
|
Cell Separation | 2 | 2010 | 149 | 0.070 |
Why?
|
Allosteric Regulation | 1 | 2007 | 69 | 0.070 |
Why?
|
DNA, Single-Stranded | 1 | 2008 | 100 | 0.070 |
Why?
|
Host-Parasite Interactions | 2 | 2008 | 54 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 89 | 0.070 |
Why?
|
Self Tolerance | 1 | 2006 | 18 | 0.070 |
Why?
|
Peptide Hydrolases | 2 | 2020 | 78 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 1447 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 384 | 0.070 |
Why?
|
Chronic Disease | 2 | 2022 | 731 | 0.070 |
Why?
|
Sepsis | 1 | 2010 | 280 | 0.070 |
Why?
|
Pandemics | 2 | 2022 | 606 | 0.070 |
Why?
|
Receptors, Mitogen | 1 | 2006 | 6 | 0.070 |
Why?
|
Dengue Virus | 1 | 2006 | 95 | 0.070 |
Why?
|
Bordetella Infections | 1 | 2005 | 2 | 0.070 |
Why?
|
Fibroblasts | 2 | 2020 | 367 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 1518 | 0.060 |
Why?
|
Plasmodium falciparum | 1 | 2007 | 132 | 0.060 |
Why?
|
Antigens, Fungal | 1 | 2006 | 54 | 0.060 |
Why?
|
Lipids | 2 | 2019 | 305 | 0.060 |
Why?
|
Mice, Nude | 2 | 2019 | 259 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 677 | 0.060 |
Why?
|
Bacillus anthracis | 2 | 2017 | 12 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 827 | 0.060 |
Why?
|
Plasmids | 2 | 2004 | 282 | 0.060 |
Why?
|
Ketoglutaric Acids | 1 | 2025 | 9 | 0.060 |
Why?
|
Filariasis | 1 | 2025 | 22 | 0.060 |
Why?
|
Terpenes | 2 | 2016 | 25 | 0.060 |
Why?
|
Myelopoiesis | 1 | 2025 | 15 | 0.060 |
Why?
|
Deoxyadenosines | 1 | 2024 | 3 | 0.060 |
Why?
|
Pneumonia, Bacterial | 1 | 2005 | 86 | 0.060 |
Why?
|
Phacoemulsification | 1 | 2024 | 6 | 0.060 |
Why?
|
Glycoproteins | 1 | 2006 | 193 | 0.060 |
Why?
|
Poxviridae | 1 | 2004 | 5 | 0.060 |
Why?
|
Allergy and Immunology | 1 | 2024 | 7 | 0.060 |
Why?
|
Cryptococcus neoformans | 1 | 2006 | 141 | 0.060 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2024 | 4 | 0.060 |
Why?
|
Macular Degeneration | 2 | 2019 | 176 | 0.060 |
Why?
|
Carboxy-Lyases | 1 | 2024 | 6 | 0.060 |
Why?
|
Hydro-Lyases | 1 | 2024 | 8 | 0.060 |
Why?
|
Receptors, Glucocorticoid | 1 | 2024 | 27 | 0.060 |
Why?
|
Vaccines, Conjugate | 1 | 2004 | 18 | 0.060 |
Why?
|
Peroxisomes | 1 | 2024 | 10 | 0.060 |
Why?
|
Prospective Studies | 2 | 2024 | 3095 | 0.060 |
Why?
|
Listeria monocytogenes | 2 | 2016 | 33 | 0.060 |
Why?
|
Nucleosides | 1 | 2023 | 11 | 0.060 |
Why?
|
Blood Proteins | 1 | 2023 | 72 | 0.050 |
Why?
|
Amphotericin B | 1 | 2003 | 22 | 0.050 |
Why?
|
Pentoxifylline | 1 | 2003 | 9 | 0.050 |
Why?
|
Melphalan | 1 | 2003 | 22 | 0.050 |
Why?
|
History, 21st Century | 1 | 2024 | 161 | 0.050 |
Why?
|
CD40 Antigens | 1 | 2023 | 60 | 0.050 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2003 | 31 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 65 | 0.050 |
Why?
|
Sarcoma | 1 | 2003 | 34 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 293 | 0.050 |
Why?
|
Solubility | 2 | 2018 | 173 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2003 | 31 | 0.050 |
Why?
|
Cell Movement | 2 | 2017 | 422 | 0.050 |
Why?
|
History, 20th Century | 1 | 2024 | 226 | 0.050 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2003 | 25 | 0.050 |
Why?
|
Brefeldin A | 1 | 2002 | 8 | 0.050 |
Why?
|
Schistosoma mansoni | 1 | 2002 | 6 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2019 | 106 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 324 | 0.050 |
Why?
|
Lysophospholipids | 1 | 2002 | 22 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 721 | 0.050 |
Why?
|
Antibodies, Bacterial | 1 | 2004 | 192 | 0.050 |
Why?
|
Nucleotides | 1 | 2022 | 42 | 0.050 |
Why?
|
Antifungal Agents | 1 | 2003 | 117 | 0.050 |
Why?
|
Culture Media | 1 | 2003 | 77 | 0.050 |
Why?
|
Methylation | 2 | 2015 | 126 | 0.050 |
Why?
|
Extracellular Space | 2 | 2018 | 30 | 0.050 |
Why?
|
Hexuronic Acids | 1 | 2002 | 22 | 0.050 |
Why?
|
Hydrolysis | 1 | 2022 | 138 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2003 | 88 | 0.050 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2022 | 28 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2022 | 25 | 0.050 |
Why?
|
Genome | 1 | 2024 | 253 | 0.050 |
Why?
|
Cecum | 1 | 2022 | 15 | 0.050 |
Why?
|
Cell Wall | 1 | 2003 | 113 | 0.050 |
Why?
|
Oxo-Acid-Lyases | 1 | 2021 | 3 | 0.050 |
Why?
|
Lipid Peroxidation | 1 | 2022 | 64 | 0.050 |
Why?
|
Chemokine CCL5 | 3 | 2009 | 33 | 0.050 |
Why?
|
Porins | 1 | 2002 | 79 | 0.050 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2021 | 6 | 0.050 |
Why?
|
Toll-Like Receptor 5 | 1 | 2021 | 11 | 0.050 |
Why?
|
Blood Cells | 2 | 2015 | 18 | 0.050 |
Why?
|
Kidney Tubules | 1 | 2021 | 17 | 0.050 |
Why?
|
Protein Aggregates | 1 | 2021 | 18 | 0.050 |
Why?
|
Risk Assessment | 2 | 2024 | 1907 | 0.050 |
Why?
|
Nanotubes | 1 | 2021 | 23 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2015 | 103 | 0.050 |
Why?
|
United Kingdom | 1 | 2021 | 69 | 0.050 |
Why?
|
Biopolymers | 1 | 2002 | 69 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 141 | 0.050 |
Why?
|
Ubiquitins | 1 | 2021 | 41 | 0.050 |
Why?
|
Macaca | 1 | 2021 | 30 | 0.050 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2022 | 97 | 0.050 |
Why?
|
Biomedical Research | 1 | 2024 | 250 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2021 | 77 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 375 | 0.050 |
Why?
|
Streptozocin | 1 | 2021 | 20 | 0.050 |
Why?
|
Vaccinia virus | 2 | 2013 | 71 | 0.050 |
Why?
|
Health | 1 | 2021 | 32 | 0.050 |
Why?
|
HIV | 1 | 2021 | 69 | 0.050 |
Why?
|
Epidemics | 1 | 2021 | 22 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2021 | 140 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 195 | 0.050 |
Why?
|
Integrins | 1 | 2021 | 108 | 0.050 |
Why?
|
Fatty Liver | 1 | 2022 | 97 | 0.050 |
Why?
|
BCG Vaccine | 1 | 2021 | 43 | 0.050 |
Why?
|
Permeability | 1 | 2020 | 47 | 0.050 |
Why?
|
Specimen Handling | 1 | 2021 | 57 | 0.040 |
Why?
|
Simian Immunodeficiency Virus | 1 | 2021 | 79 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2012 | 1470 | 0.040 |
Why?
|
Cystatin B | 1 | 2020 | 1 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 35 | 0.040 |
Why?
|
Stroke Volume | 1 | 2022 | 317 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 262 | 0.040 |
Why?
|
Gene Deletion | 1 | 2021 | 298 | 0.040 |
Why?
|
ROC Curve | 1 | 2021 | 259 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 192 | 0.040 |
Why?
|
Optical Imaging | 1 | 2021 | 68 | 0.040 |
Why?
|
Serine | 1 | 2020 | 83 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 175 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 4997 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2022 | 307 | 0.040 |
Why?
|
Home Care Services | 1 | 2021 | 103 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2019 | 9 | 0.040 |
Why?
|
Actins | 1 | 2021 | 260 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2021 | 247 | 0.040 |
Why?
|
Fatty Acids | 1 | 2021 | 194 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 209 | 0.040 |
Why?
|
Virus Replication | 1 | 2021 | 304 | 0.040 |
Why?
|
Europe | 1 | 2020 | 182 | 0.040 |
Why?
|
Melanoma | 1 | 2003 | 334 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 117 | 0.040 |
Why?
|
Alleles | 1 | 2021 | 425 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2022 | 299 | 0.040 |
Why?
|
omega-Chloroacetophenone | 1 | 2018 | 2 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2018 | 20 | 0.040 |
Why?
|
Nephrectomy | 1 | 2019 | 49 | 0.040 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2019 | 59 | 0.040 |
Why?
|
Histocompatibility Antigens | 1 | 2019 | 107 | 0.040 |
Why?
|
Genotype | 1 | 2021 | 644 | 0.040 |
Why?
|
alpha-2-HS-Glycoprotein | 1 | 2018 | 2 | 0.040 |
Why?
|
Scavenger Receptors, Class A | 1 | 2018 | 5 | 0.040 |
Why?
|
Intravital Microscopy | 1 | 2018 | 12 | 0.040 |
Why?
|
Piracetam | 1 | 2018 | 8 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2013 | 427 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 78 | 0.040 |
Why?
|
Potassium | 1 | 2019 | 109 | 0.040 |
Why?
|
Minerals | 1 | 2018 | 19 | 0.040 |
Why?
|
Collagen | 1 | 2019 | 121 | 0.040 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2018 | 39 | 0.040 |
Why?
|
Computational Biology | 1 | 2020 | 325 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 52 | 0.040 |
Why?
|
Colloids | 1 | 2018 | 49 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 462 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 646 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2003 | 403 | 0.040 |
Why?
|
Spatial Memory | 1 | 2017 | 7 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 35 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2017 | 31 | 0.040 |
Why?
|
Elasticity Imaging Techniques | 1 | 2018 | 21 | 0.040 |
Why?
|
Exodeoxyribonucleases | 1 | 2017 | 28 | 0.040 |
Why?
|
Calcinosis | 1 | 2018 | 78 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2017 | 52 | 0.040 |
Why?
|
A549 Cells | 1 | 2017 | 36 | 0.040 |
Why?
|
Cell Survival | 2 | 2014 | 553 | 0.040 |
Why?
|
Telomere | 1 | 2017 | 47 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 83 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 162 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 72 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2017 | 32 | 0.040 |
Why?
|
MCF-7 Cells | 1 | 2017 | 65 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 236 | 0.040 |
Why?
|
Mice, Obese | 1 | 2017 | 79 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2017 | 191 | 0.040 |
Why?
|
Nigericin | 1 | 2017 | 4 | 0.040 |
Why?
|
Pyrin Domain | 1 | 2017 | 3 | 0.040 |
Why?
|
Hypothalamus | 1 | 2017 | 120 | 0.040 |
Why?
|
Leukocidins | 1 | 2017 | 8 | 0.040 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2017 | 2 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2018 | 124 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2016 | 52 | 0.030 |
Why?
|
Proteins | 1 | 2022 | 742 | 0.030 |
Why?
|
Sex Factors | 1 | 2020 | 959 | 0.030 |
Why?
|
Splenic Diseases | 1 | 2016 | 14 | 0.030 |
Why?
|
Beclin-1 | 1 | 2016 | 20 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 2016 | 28 | 0.030 |
Why?
|
Cholagogues and Choleretics | 1 | 2016 | 5 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2016 | 65 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 14 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2017 | 231 | 0.030 |
Why?
|
Survival Analysis | 1 | 2018 | 553 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 375 | 0.030 |
Why?
|
Oxalates | 1 | 2016 | 17 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 248 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2016 | 97 | 0.030 |
Why?
|
Invertebrates | 1 | 2016 | 19 | 0.030 |
Why?
|
Plants | 1 | 2016 | 42 | 0.030 |
Why?
|
Hippocampus | 1 | 2017 | 238 | 0.030 |
Why?
|
Adenine | 1 | 2016 | 46 | 0.030 |
Why?
|
Cognition | 1 | 2020 | 459 | 0.030 |
Why?
|
Taurine | 1 | 2015 | 5 | 0.030 |
Why?
|
Germ-Free Life | 1 | 2015 | 9 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 141 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2016 | 145 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 304 | 0.030 |
Why?
|
Streptococcal Infections | 1 | 2016 | 77 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2016 | 88 | 0.030 |
Why?
|
Leukocytes | 1 | 2016 | 108 | 0.030 |
Why?
|
Body Weight | 1 | 2017 | 378 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2015 | 8 | 0.030 |
Why?
|
CX3C Chemokine Receptor 1 | 1 | 2015 | 10 | 0.030 |
Why?
|
Isoenzymes | 1 | 2016 | 134 | 0.030 |
Why?
|
Complement C3c | 1 | 2015 | 1 | 0.030 |
Why?
|
Complement Membrane Attack Complex | 1 | 2015 | 5 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 219 | 0.030 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2015 | 45 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 70 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2015 | 54 | 0.030 |
Why?
|
CD11b Antigen | 1 | 2015 | 22 | 0.030 |
Why?
|
Acute Disease | 1 | 2017 | 658 | 0.030 |
Why?
|
CD18 Antigens | 1 | 2015 | 30 | 0.030 |
Why?
|
Nootropic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
Locus Coeruleus | 1 | 2015 | 21 | 0.030 |
Why?
|
Species Specificity | 1 | 2016 | 336 | 0.030 |
Why?
|
Kinetics | 2 | 2008 | 733 | 0.030 |
Why?
|
Calgranulin B | 1 | 2014 | 6 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2015 | 72 | 0.030 |
Why?
|
Pulmonary Alveoli | 1 | 2014 | 43 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 281 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2017 | 348 | 0.030 |
Why?
|
Web Browser | 1 | 2014 | 5 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2014 | 52 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2014 | 28 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 59 | 0.030 |
Why?
|
RNA Editing | 1 | 2014 | 21 | 0.030 |
Why?
|
Glucose | 1 | 2017 | 444 | 0.030 |
Why?
|
Interferon Regulatory Factor-7 | 2 | 2005 | 33 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 5914 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 291 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 2014 | 36 | 0.030 |
Why?
|
Complement C5 | 1 | 2014 | 9 | 0.030 |
Why?
|
Complement C1q | 1 | 2014 | 8 | 0.030 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2013 | 2 | 0.030 |
Why?
|
Complement Pathway, Classical | 1 | 2014 | 23 | 0.030 |
Why?
|
DNA Methylation | 1 | 2016 | 274 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2016 | 846 | 0.030 |
Why?
|
Macrophage-1 Antigen | 1 | 2014 | 31 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2014 | 61 | 0.030 |
Why?
|
Podocytes | 1 | 2013 | 8 | 0.030 |
Why?
|
CHO Cells | 2 | 2006 | 191 | 0.030 |
Why?
|
Thioredoxins | 1 | 2013 | 15 | 0.030 |
Why?
|
Survival Rate | 1 | 2016 | 787 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 85 | 0.030 |
Why?
|
Complement Pathway, Alternative | 1 | 2014 | 27 | 0.030 |
Why?
|
Antigens, CD | 2 | 2008 | 343 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2014 | 64 | 0.030 |
Why?
|
Drug Combinations | 1 | 2014 | 140 | 0.030 |
Why?
|
BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
I-kappa B Kinase | 2 | 2004 | 48 | 0.030 |
Why?
|
Gap Junctions | 1 | 2013 | 16 | 0.030 |
Why?
|
Plasmodium | 1 | 2014 | 29 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 2013 | 26 | 0.030 |
Why?
|
Point Mutation | 1 | 2014 | 162 | 0.030 |
Why?
|
Cricetinae | 2 | 2006 | 377 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 64 | 0.030 |
Why?
|
Pregnancy | 1 | 2021 | 2352 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2006 | 179 | 0.030 |
Why?
|
Blood Glucose | 1 | 2015 | 470 | 0.030 |
Why?
|
Erythrocytes | 1 | 2014 | 155 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 192 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 124 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 659 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2014 | 353 | 0.030 |
Why?
|
Vinculin | 1 | 2012 | 3 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2013 | 184 | 0.030 |
Why?
|
Camptothecin | 1 | 2012 | 23 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2012 | 16 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 9 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 20 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 131 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 67 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2012 | 111 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 47 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 875 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 52 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2012 | 51 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 439 | 0.020 |
Why?
|
Memory | 1 | 2012 | 116 | 0.020 |
Why?
|
Pilot Projects | 1 | 2015 | 918 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 230 | 0.020 |
Why?
|
Neuroglia | 1 | 2012 | 79 | 0.020 |
Why?
|
Thermodynamics | 1 | 2012 | 194 | 0.020 |
Why?
|
Phosphorothioate Oligonucleotides | 1 | 2011 | 10 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2017 | 749 | 0.020 |
Why?
|
Candidiasis | 1 | 2011 | 40 | 0.020 |
Why?
|
Candida | 1 | 2011 | 34 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2012 | 214 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 94 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 193 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 77 | 0.020 |
Why?
|
Greece | 1 | 2010 | 3 | 0.020 |
Why?
|
Germany | 1 | 2010 | 51 | 0.020 |
Why?
|
Uridine | 1 | 2010 | 16 | 0.020 |
Why?
|
Dextran Sulfate | 1 | 2010 | 37 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2010 | 28 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 126 | 0.020 |
Why?
|
Ribose | 1 | 2009 | 3 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2010 | 72 | 0.020 |
Why?
|
Ultracentrifugation | 1 | 2009 | 28 | 0.020 |
Why?
|
X-Rays | 1 | 2009 | 44 | 0.020 |
Why?
|
Oligoribonucleotides | 1 | 2009 | 14 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 197 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2009 | 72 | 0.020 |
Why?
|
Algorithms | 1 | 2014 | 986 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2009 | 112 | 0.020 |
Why?
|
Cross Infection | 1 | 2010 | 150 | 0.020 |
Why?
|
ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2008 | 17 | 0.020 |
Why?
|
United States | 1 | 2021 | 7492 | 0.020 |
Why?
|
Apolipoprotein A-I | 1 | 2008 | 22 | 0.020 |
Why?
|
Retroelements | 1 | 2008 | 39 | 0.020 |
Why?
|
Pattern Recognition, Physiological | 1 | 2008 | 4 | 0.020 |
Why?
|
Hepatocytes | 1 | 2009 | 189 | 0.020 |
Why?
|
Cathepsin K | 1 | 2008 | 7 | 0.020 |
Why?
|
Freund's Adjuvant | 1 | 2008 | 13 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 148 | 0.020 |
Why?
|
Dinucleoside Phosphates | 1 | 2008 | 38 | 0.020 |
Why?
|
Bone Resorption | 1 | 2008 | 49 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2008 | 104 | 0.020 |
Why?
|
Virus Activation | 1 | 2006 | 24 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2007 | 42 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2006 | 49 | 0.020 |
Why?
|
Osteoporosis | 1 | 2008 | 137 | 0.020 |
Why?
|
Glycation End Products, Advanced | 1 | 2006 | 19 | 0.020 |
Why?
|
Myristic Acid | 1 | 2006 | 9 | 0.020 |
Why?
|
Neurons | 1 | 2012 | 858 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2008 | 684 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2010 | 446 | 0.020 |
Why?
|
Cricetulus | 1 | 2006 | 102 | 0.020 |
Why?
|
CD11c Antigen | 1 | 2006 | 8 | 0.020 |
Why?
|
Dynamins | 1 | 2006 | 12 | 0.020 |
Why?
|
Mannose-Binding Lectins | 1 | 2006 | 21 | 0.020 |
Why?
|
Clathrin | 1 | 2006 | 23 | 0.020 |
Why?
|
Bordetella bronchiseptica | 1 | 2005 | 2 | 0.020 |
Why?
|
Bordetella parapertussis | 1 | 2005 | 2 | 0.020 |
Why?
|
K562 Cells | 1 | 2006 | 58 | 0.020 |
Why?
|
Viral Fusion Proteins | 1 | 2006 | 74 | 0.020 |
Why?
|
Bordetella pertussis | 1 | 2005 | 10 | 0.020 |
Why?
|
HLA Antigens | 1 | 2006 | 59 | 0.020 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 53 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 183 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2006 | 82 | 0.020 |
Why?
|
Lipid A | 1 | 2005 | 70 | 0.020 |
Why?
|
Dogs | 1 | 2006 | 316 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2005 | 32 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 177 | 0.020 |
Why?
|
Electroporation | 1 | 2005 | 32 | 0.020 |
Why?
|
Biological Assay | 1 | 2005 | 54 | 0.010 |
Why?
|
Rats | 1 | 2008 | 1907 | 0.010 |
Why?
|
Zymosan | 1 | 2003 | 23 | 0.010 |
Why?
|
Toll-Like Receptor 1 | 1 | 2003 | 22 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2003 | 32 | 0.010 |
Why?
|
Biotinylation | 1 | 2003 | 38 | 0.010 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2003 | 6 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2003 | 103 | 0.010 |
Why?
|
Extremities | 1 | 2003 | 50 | 0.010 |
Why?
|
Chimera | 1 | 2003 | 42 | 0.010 |
Why?
|
Cysteine | 1 | 2003 | 107 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 357 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 2034 | 0.010 |
Why?
|
B7-2 Antigen | 1 | 2002 | 32 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 292 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 694 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2002 | 213 | 0.010 |
Why?
|